Ontario patient wins court review in OHIP funding dispute for US cancer treatment
Alex Shved, an Ontario man with Stage 4 melanoma, challenged the provincial health plan (OHIP) after it denied funding for specialized cell therapy in Florida. A court ordered OHIP to reconsider his request for the treatment, which costs approximately US$600,000. The health plan subsequently rejected the request a second time. During this process, Ontario changed its regulations, further limiting public coverage for out-of-country drug treatments.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.
Discussion (0)
Log in to join the discussion and vote.
Log in